Spire Healthcare Group plc (LON:SPI)
London
· Delayed Price · Currency is GBP · Price in GBX 191.60
+1.60 (0.84%)
At close: Mar 6, 2026
Spire Healthcare Group Income Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 1,580 | 1,511 | 1,359 | 1,199 | 1,106 | Upgrade
|
| Revenue Growth (YoY) | 4.54% | 11.20% | 13.39% | 8.34% | 20.25% | Upgrade
|
| Cost of Revenue | 863.7 | 827.6 | 734.8 | 660.1 | 615 | Upgrade
|
| Gross Profit | 716.1 | 683.6 | 624.2 | 538.4 | 491.2 | Upgrade
|
| Selling, General & Admin | 609.8 | 20.4 | 18.6 | 13.6 | 12.3 | Upgrade
|
| Amortization of Goodwill & Intangibles | 4.1 | 4.2 | 0.6 | - | - | Upgrade
|
| Other Operating Expenses | -157.4 | 406.8 | 375.2 | 324.3 | 301.8 | Upgrade
|
| Operating Expenses | 570.5 | 539.4 | 497.4 | 435.8 | 411.2 | Upgrade
|
| Operating Income | 145.6 | 144.2 | 126.8 | 102.6 | 80 | Upgrade
|
| Interest Expense | -103.5 | -98.4 | -91.5 | -85.9 | -87 | Upgrade
|
| Interest & Investment Income | 1 | 0.7 | 1.4 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 0.3 | - | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | 43.4 | 46.5 | 36.7 | 16.7 | -7 | Upgrade
|
| Merger & Restructuring Charges | -21.3 | -4.3 | -4.5 | -6.3 | -1.2 | Upgrade
|
| Gain (Loss) on Sale of Investments | 3.1 | 5.8 | 3.6 | 3 | 1.1 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 5.2 | - | - | 18.8 | Upgrade
|
| Asset Writedown | -0.5 | - | - | -0.5 | - | Upgrade
|
| Legal Settlements | - | -4.6 | -2.5 | -0.3 | -12.2 | Upgrade
|
| Other Unusual Items | -6.1 | -10.3 | -1.2 | -8.7 | -1.4 | Upgrade
|
| Pretax Income | 18.6 | 38.3 | 34.6 | 3.9 | -1.9 | Upgrade
|
| Income Tax Expense | 1.4 | 12.3 | 6.7 | -4.3 | 7 | Upgrade
|
| Earnings From Continuing Operations | 17.2 | 26 | 27.9 | 8.2 | -8.9 | Upgrade
|
| Minority Interest in Earnings | -0.8 | -0.6 | -0.6 | 0.4 | -0.8 | Upgrade
|
| Net Income | 16.4 | 25.4 | 27.3 | 8.6 | -9.7 | Upgrade
|
| Net Income to Common | 16.4 | 25.4 | 27.3 | 8.6 | -9.7 | Upgrade
|
| Net Income Growth | -35.43% | -6.96% | 217.44% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 400 | 403 | 404 | 403 | 401 | Upgrade
|
| Shares Outstanding (Diluted) | 405 | 411 | 413 | 412 | 401 | Upgrade
|
| Shares Change (YoY) | -1.48% | -0.42% | 0.27% | 2.79% | 0.00% | Upgrade
|
| EPS (Basic) | 0.04 | 0.06 | 0.07 | 0.02 | -0.02 | Upgrade
|
| EPS (Diluted) | 0.04 | 0.06 | 0.07 | 0.02 | -0.02 | Upgrade
|
| EPS Growth | -35.48% | -6.06% | 214.30% | - | - | Upgrade
|
| Free Cash Flow | 165.9 | 126.4 | 131.6 | 93.9 | 114.5 | Upgrade
|
| Free Cash Flow Per Share | 0.41 | 0.31 | 0.32 | 0.23 | 0.29 | Upgrade
|
| Dividend Per Share | 0.015 | 0.023 | 0.021 | 0.005 | - | Upgrade
|
| Dividend Growth | -34.78% | 9.52% | 320.00% | - | - | Upgrade
|
| Gross Margin | 45.33% | 45.24% | 45.93% | 44.92% | 44.40% | Upgrade
|
| Operating Margin | 9.22% | 9.54% | 9.33% | 8.56% | 7.23% | Upgrade
|
| Profit Margin | 1.04% | 1.68% | 2.01% | 0.72% | -0.88% | Upgrade
|
| Free Cash Flow Margin | 10.50% | 8.36% | 9.68% | 7.83% | 10.35% | Upgrade
|
| EBITDA | 215.3 | 213.1 | 192.5 | 166.8 | 147.4 | Upgrade
|
| EBITDA Margin | 13.63% | 14.10% | 14.16% | 13.92% | 13.33% | Upgrade
|
| D&A For EBITDA | 69.7 | 68.9 | 65.7 | 64.2 | 67.4 | Upgrade
|
| EBIT | 145.6 | 144.2 | 126.8 | 102.6 | 80 | Upgrade
|
| EBIT Margin | 9.22% | 9.54% | 9.33% | 8.56% | 7.23% | Upgrade
|
| Effective Tax Rate | 7.53% | 32.12% | 19.36% | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.